Ray Takigiku, President and CEO of Bexion Pharmaceuticals Inc., stands for a portrait in the company's lab, Thursday, July 5, 2018, Covington, Ky. Bexion Pharmaceuticals Inc. is the developer behind the experimental drug BXQ-350
{}